AMAndres F. Marmolejo-Valencia

Andres F. Marmolejo-Valencia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Andres F. Marmolejo-Valencia has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Encoding mu-opioid receptor biased agonism with interaction fingerprints

    by R. Bruno Hernández-Alvarado, Abraham Madariaga-Mazón, Fernando Cosme-Vela, Andrés F. Marmolejo-Valencia, Adel Nefzi, Karina Martinez-Mayorga

    Opioids are potent painkillers, however, their therapeutic use requires close medical monitoring to diminish the risk of severe adverse effects. The G-protein biased agonists of the μ-opioid receptor (MOR) have shown safer therapeutic profiles than non-biased ligands. In this work, we performed extensive all-atom molecular dynamics simulations of two markedly biased ligands and a balanced reference molecule. From those simulations, we identified a protein–ligand interaction fingerprint that characterizes biased ligands. Then, we built and virtually screened a database containing 68,740 ligands with proven or potential GPCR agonistic activity. Exemplary molecules that fulfill the interacting pattern for biased agonism are showcased, illustrating the usefulness of this work for the search of biased MOR ligands and how this contributes to the understanding of MOR biased signaling.


  • Charge-transfer electronic states in organic solar cells: a TDDFT study

    by Andres F. Marmolejo-Valencia, Zaahel Mata-Pinzón, Carlos Amador-Bedolla

    Prediction of new organic photovoltaic materials in solar cells must include a precise description of charge-transfer states that are involved in electron-transfer processes such as charge separation and charge recombination which govern efficiency.


  • Open Access

    Bias-inducing allosteric binding site in mu-opioid receptor signaling

    by Andrés F. Marmolejo-Valencia, Abraham Madariaga-Mazón, Karina Martinez-Mayorga

    G-protein-biased agonism of the mu-opioid receptor (μ-OR) is emerging as a promising strategy in analgesia. A deep understanding of how biased agonists modulate and differentiate G-protein-coupled receptors (GPCR) signaling pathways and how this is transferred into the cell are open questions. Here, using extensive all-atom molecular dynamics simulations, we analyzed the binding recognition process and signaling effects of three prototype μ-OR agonists. Our suggested structural mechanism of biased signaling in μ-OR involves an allosteric sodium ion site, water networks, conformational rearrangements in conserved motifs and collective motions of loops and transmembrane helices. These analyses led us to highlight the relevance of a bias-inducing allosteric binding site in the understanding of μ-OR’s G-protein-biased signaling. These results also suggest a competitive equilibrium between the agonists and the allosteric sodium ion, where the bias-inducing allosteric binding site can be modulated by this ion or an agonist such as herkinorin. Notably, herkinorin arises as the archetype modulator of μ-OR and its interactive pattern could be used for screening efforts via protein–ligand interaction fingerprint (PLIF) studies. Article highlights: Agonists and a sodium ion compete for the bias-inducing allosteric binding site that modulates signaling in mu-opioid receptors. Molecular dynamics simulations of the prototype μ-OR agonist suggest a competitive equilibrium involving the agonist and an allosteric sodium ion. Analysis of experimental data from the literature and molecular models provides the structural bases of biased agonism on μ-OR.


  • Atomistic simulations of bulk heterojunctions to evaluate the structural and packing properties of new predicted donors in OPVs

    by Andrés F. Marmolejo-Valencia, Zaahel Mata-Pinzón, Laura Dominguez, Carlos Amador-Bedolla

    Electronic and packing properties exploration of BHJ with new predicted donors can lead to better optimized phases.